{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:23:52Z","timestamp":1790108632284,"version":"4.0.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,11,26]],"date-time":"2008-11-26T00:00:00Z","timestamp":1227657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1007\/s00417-008-1002-5","type":"journal-article","created":{"date-parts":[[2008,12,3]],"date-time":"2008-12-03T18:47:02Z","timestamp":1228330022000},"page":"675-680","source":"Crossref","is-referenced-by-count":44,"title":["Interferon-alpha-associated presumed ocular sarcoidosis"],"prefix":"10.1007","volume":"247","author":[{"given":"Deshka","family":"Doycheva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Deuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Stuebiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Zierhut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,11,26]]},"reference":[{"key":"1002_CR1","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/1097-0142(19870301)59:5<896::AID-CNCR2820590507>3.0.CO;2-4","volume":"59","author":"EA Abdi","year":"1987","unstructured":"Abdi EA, Nguyen GK, Ludwig RN, Dickout WJ (1987) Pulmonary sarcoidosis following interferon therapy for advanced renal cell carcinoma. Cancer 59:896\u2013900. doi: 10.1002\/1097-0142(19870301)59:5<896::AID-CNCR2820590507>3.0.CO;2-4","journal-title":"Cancer"},{"key":"1002_CR2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1742-1241.2005.00651.x","volume":"60","author":"S Alazemi","year":"2006","unstructured":"Alazemi S, Campos MA (2006) Interferon-induced sarcoidosis. Int J Clin Pract 60:201\u2013211, doi: 10.1111\/j.1742\u20131241.2005.00651.x","journal-title":"Int J Clin Pract"},{"key":"1002_CR3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000081276","volume":"112","author":"K Arimura","year":"2004","unstructured":"Arimura K, Arima N, Ohtsubo H, Matsushita K, Kukita T, Ayukawa T, Kuroki T, Tei C (2004) Severe autoimmune thrombocytopenic purpura during interferon-alpha therapy for chronic myelogenous leukemia. Acta Haematol 112:217\u2013218, doi: 10.1159\/000081276","journal-title":"Acta Haematol"},{"key":"1002_CR4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/107999002753452665","volume":"22","author":"B Barnes","year":"2002","unstructured":"Barnes B, Lubyova B, Pitha PM (2002) On the role of IFN in host defense. J Interferon Cytokine Res 22:59\u201371, doi: 10.1089\/107999002753452665","journal-title":"J Interferon Cytokine Res"},{"key":"1002_CR5","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/jama.1991.03470100067035","volume":"266","author":"S Baron","year":"1991","unstructured":"Baron S, Tyring SK, Fleischmann WR Jr, Coppenhaver DH, Niesel DW, Klimpel GR, Stanton GJ, Hughes TK (1991) The interferons. Mechanisms of action and clinical applications. JAMA 266:1375\u20131383, doi: 10.1001\/jama.266.10.1375","journal-title":"JAMA"},{"key":"1002_CR6","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/0006-2952(90)90437-P","volume":"40","author":"A Billiau","year":"1990","unstructured":"Billiau A, Dijkmans R (1990) Interferon-gamma: mechanism of action and therapeutic potential. Biochem Pharmacol 40:1433\u20131439, doi: 10.1016\/0006-2952(90)90437-P","journal-title":"Biochem Pharmacol"},{"key":"1002_CR7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/bjo.2006.101550","volume":"91","author":"B Bodaghi","year":"2007","unstructured":"Bodaghi B, Gendron G, Wechsler B, Terrada C, Cassoux N, du Huong LT, Lemaitre C, Fradeau C, LeHoang P, Piette JC (2007) Efficacy of interferon alpha in the treatment of refractory and sight-threatening uveitis: a retrospective monocentric study of 45 patients. Br J Ophthalmol 91:335\u2013339, doi: 10.1136\/bjo.2006.101550","journal-title":"Br J Ophthalmol"},{"key":"1002_CR8","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/01.pas.0000160442.23523.0a","volume":"29","author":"KJ Butnor","year":"2005","unstructured":"Butnor KJ (2005) Pulmonary sarcoidosis induced by interferon-alpha therapy. Am J Surg Pathol 29:976\u2013979, doi: 10.1097\/01.pas.0000160442.23523.0a","journal-title":"Am J Surg Pathol"},{"key":"1002_CR9","first-page":"364","volume":"24","author":"P Cacoub","year":"2000","unstructured":"Cacoub P, Sbai A, Frances C, Genesti C, Hausfater P, Piette JC (2000) Systemic sarcoidosis during interferon-alpha therapy for chronic hepatitis C virus infection. Gastroenterol Clin Biol 24:364\u2013366","journal-title":"Gastroenterol Clin Biol"},{"key":"1002_CR10","doi-asserted-by":"crossref","first-page":"522","DOI":"10.4049\/jimmunol.157.2.522","volume":"157","author":"D Chakrabarti","year":"1996","unstructured":"Chakrabarti D, Hultgren B, Stewart TA (1996) IFN-alpha induces autoimmune T cells through the induction of intracellular adhesion molecule-1 and B7.2. J Immunol 157:522\u2013528","journal-title":"J Immunol"},{"key":"1002_CR11","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1002\/1097-0142(19900515)65:10<2237::AID-CNCR2820651013>3.0.CO;2-5","volume":"65","author":"KC Conlon","year":"1990","unstructured":"Conlon KC, Urba WJ, Smith JW, Steis RG, Congo DL, Clark JW (1990) Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy. Cancer 65:2237\u20132242, doi: 10.1002\/1097-0142(19900515)65:10<2237::AID-CNCR2820651013>3.0.CO;2-5","journal-title":"Cancer"},{"key":"1002_CR12","first-page":"164","volume":"3","author":"GE Dean","year":"1995","unstructured":"Dean GE, Spears L, Ferrell BR, Quan WD, Groshon S, Mitchell MS (1995) Fatigue in patients with cancer receiving interferon alpha. Cancer Pract 3:164\u2013172","journal-title":"Cancer Pract"},{"key":"1002_CR13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/0-306-48382-3_105","volume":"528","author":"CM Deuter","year":"2003","unstructured":"Deuter CM, K\u00f6tter I, G\u00fcnaydin I, Zierhut M, St\u00fcbiger N (2003) Behcet\u2019s disease: visual acuity after 5 years in patients with alpha-interferon treatment. Adv Exp Mol Biol 528:525\u2013528, doi: 10.1007\/0-306-48382-3_105","journal-title":"Adv Exp Mol Biol"},{"key":"1002_CR14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0168-8278(96)80184-X","volume":"24","author":"G Fattovich","year":"1996","unstructured":"Fattovich G, Giustina G, Favarato S, Ruol A (1996) A survey of adverse events in 11,241 patints with chrinic viral hepatitis treated with alpha interferon. J Hepatol 24:38\u201347, doi: 10.1016\/S0168-8278(96)80184-X","journal-title":"J Hepatol"},{"key":"1002_CR15","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/273759a0","volume":"273","author":"M Gidlund","year":"1978","unstructured":"Gidlund M, Orn A, Wigzell H, Senik A, Gresser I (1978) Enhanced NK cell activity in mice injected with interferon and interferon inducers. Nature 273:759\u2013761, doi: 10.1038\/273759a0","journal-title":"Nature"},{"key":"1002_CR16","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/archopht.1993.01090030068041","volume":"111","author":"DR Guyer","year":"1993","unstructured":"Guyer DR, Tiedeman J, Yannuzzi LE, Slakter JS, Parke D, Kelly J, Tang RA, Marmor M, Abraham G, Miller JW (1993) Interferon associated retinopathy. Arch Ophthalmol 111:350\u2013356","journal-title":"Arch Ophthalmol"},{"key":"1002_CR17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/bjo.82.3.323","volume":"82","author":"S Hayasaka","year":"1998","unstructured":"Hayasaka S, Nagaki Y, Matsumoto M, Sato S (1998) Interferon associated retinopathy. Br J Ophthalmol 82:323\u2013325","journal-title":"Br J Ophthalmol"},{"key":"1002_CR18","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.4049\/jimmunol.161.4.2011","volume":"161","author":"P Hermann","year":"1998","unstructured":"Hermann P, Rubio M, Nakajima T, Delespesse G, Sarfati M (1998) IFN-alpha priming of human monocytes dufferentially regulates gram-positive and gram-negative bacteria-induced IL-10 release and selectively enhances IL-12p70, CD80 and MHC class I expression. J Immunol 161:2011\u20132018","journal-title":"J Immunol"},{"key":"1002_CR19","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1440-1843.2005.00745.x","volume":"10","author":"A Hirano","year":"2005","unstructured":"Hirano A, kataoka M, Nakata Y, Takeda K, Kamao T, Hiramatsu J, Kimura G, Tanimoto Y, Kanehiro A, Tanimoto M (2005) Sarcoidosis occurring after interferon-alpha therapy for chronic hepatitis C: report of two cases. Respirology 10:529\u2013534, doi: 10.1111\/j.1440-1843.2005.00745.x","journal-title":"Respirology"},{"key":"1002_CR20","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/ajrccm.160.2.ats4-99","volume":"160","author":"GW Hunninghake","year":"1999","unstructured":"Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, du Bois R, Eklund A, Kitaichi M, Lynch J, Rizzato G, Rose C, Selroos O, Semenzato G, Sharma OP (1999) Statement of sarcoidosis. Am J Respir Crit Care Med 160:736\u2013755","journal-title":"Am J Respir Crit Care Med"},{"key":"1002_CR21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1634\/theoncologist.6-1-34","volume":"6","author":"E Jonasch","year":"2001","unstructured":"Jonasch E, Haluska FG (2001) Interferon in oncological practice: review of interferon biology, clinical applications and toxicities. Oncologist 6:34\u201355, doi: 10.1634\/theoncologist.6-1-34","journal-title":"Oncologist"},{"key":"1002_CR22","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1007\/s00535-004-1452-4","volume":"39","author":"A Kasahara","year":"2004","unstructured":"Kasahara A, Hiraide A, Tomita N, Iwahashi H, Imagawa A, Ohguro N, Yamamoto S, Mita E, Hayashi N (2004) Vogt-Koyanagi-Harada disease occurring during interferon alpha therapy for chronic hepatitis C. J Gastroenterol 39:1106\u20131109, doi: 10.1007\/s00535-004-1452-4","journal-title":"J Gastroenterol"},{"key":"1002_CR23","first-page":"723","volume":"68","author":"SE Krown","year":"1984","unstructured":"Krown SE, Burk MW, Kirkwood JM, Kerr D, Morton DL, Oettgen HF (1984) Human leukocyte (alpha) interferon in metastatic malignant melanoma: the American Cancer Society phase II trial. Cancer Treat Rep 68:723\u2013726","journal-title":"Cancer Treat Rep"},{"key":"1002_CR24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1359-6101(00)00027-7","volume":"12","author":"DE Levy","year":"2001","unstructured":"Levy DE, Garcia-Sastre A (2001) The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion. Cytokine Growth Factor Rev 12:143\u2013156, doi: 10.1016\/S1359-6101(00)00027-7","journal-title":"Cytokine Growth Factor Rev"},{"key":"1002_CR25","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1007\/s00330-003-2207-y","volume":"14","author":"S Massaguer","year":"2004","unstructured":"Massaguer S, Sanchez M, Castel T (2004) Mediastinal sarcoidosis induced by high-dose alpha-2-interferon therapy in a patient with malignant melanoma. Eur Radiol 14:1716\u20131717, doi: 10.1007\/s00330-003-2207-y","journal-title":"Eur Radiol"},{"key":"1002_CR26","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/01.mcp.0000134400.88832.9c","volume":"10","author":"K Marzouk","year":"2004","unstructured":"Marzouk K, Saleh S, Kannass M, Sharma OP (2004) Interferon-induced granulomatous lung disease. Curr Opin Pulm Med 10:435\u2013440, doi: 10.1097\/01.mcp.0000134400.88832.9c","journal-title":"Curr Opin Pulm Med"},{"key":"1002_CR27","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1167\/iovs.06-0182","volume":"48","author":"T Nagaoka","year":"2007","unstructured":"Nagaoka T, Sato E, Takabashi A, Yokobama S, Yoshida A (2007) Retinal circulatory changes associated with interferon-induced retinopathy in patients with hepatitis C. Invest Ophthalmol Vis Sci 48:368\u2013375, doi: 10.1167\/iovs.06-0182","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1002_CR28","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.4049\/jimmunol.160.7.3487","volume":"160","author":"Q Ning","year":"1998","unstructured":"Ning Q, Brown D, Parodo J, Cattral M, Gerczynski R, Cole E, Fung L, Ding JW, Liu MF, Rotstein O, Phillips MJ, Levy G (1998) Ribavirin inhibits virus-induced macrophage production of TNF alpha, IL-1, the procoagulant fg12 prothrombinasa and preserves Th1 cytokine production but inhibits Th2 cytokine response. J Immunol 160:3487\u20133490","journal-title":"J Immunol"},{"key":"1002_CR29","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1001\/archopht.1996.01100130718014","volume":"114","author":"H Nishiwaki","year":"1996","unstructured":"Nishiwaki H, Ogura Y, Miyamoto K, Matsuda N, Honda Y (1996) Interferon alpha induces leukocyte capillary trapping in rat retinal microcirculation. Arch Ophthalmol 114:726\u2013730","journal-title":"Arch Ophthalmol"},{"key":"1002_CR30","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/00004836-200209000-00018","volume":"35","author":"K Noguchi","year":"2002","unstructured":"Noguchi K, Enjoji M, Nakamuta M, Sugimoto R, Kotoh K, Nawata H (2002) Varous sarcoid lesions in a patient induced by interferon therapy for chronic hepatitis C. J Clin Gastroenterol 35:282\u2013284, doi: 10.1097\/00004836-200209000-00018","journal-title":"J Clin Gastroenterol"},{"key":"1002_CR31","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/eji.1830260328","volume":"26","author":"P Parronchi","year":"1996","unstructured":"Parronchi P, Mohapatra S, Sampognaro S, Giannarini L, Wahn U, Chong P, Maggi E, Renz H, Romagnani S (1996) Effects of interferon-alpha on cytokine profile, T cell receptor repertoire and peptide reactivity of human allergic-specific T cells. Eur J Immunol 26:697\u2013703, doi: 10.1002\/eji.1830260328","journal-title":"Eur J Immunol"},{"key":"1002_CR32","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1212\/WNL.43.4.662","volume":"43","author":"DW Paty","year":"1993","unstructured":"Paty DW, Li DK (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS\/MRI Study Group and the IGNB Multiple Sclerosis Study Group. Neurology 43:662\u2013667","journal-title":"Neurology"},{"key":"1002_CR33","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1398-9995.2006.01058.x","volume":"61","author":"WJ Pichler","year":"2006","unstructured":"Pichler WJ (2006) Adverse side-effects to biological agents. Allergy 61:912\u2013920 doi: 10.1111\/j.1398-9995.2006.01058.x","journal-title":"Allergy"},{"key":"1002_CR34","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000057631","volume":"107","author":"P Raanani","year":"2002","unstructured":"Raanani P, Ben-Bassat I (2002) Immune-mediated complications during interferon therapy in hematological patients. Acta Haematol 107:133\u2013144, doi: 10.1159\/000057631","journal-title":"Acta Haematol"},{"key":"1002_CR35","first-page":"69","volume":"84","author":"M Ramos-Casals","year":"2005","unstructured":"Ramos-Casals M, Mana J, Nardi N, Brito-Zeron P, Xauber A, Sanchez-Tapias JM, Cervera R, Font J (2005) Sarcoidosis in patients with chronic hepatitis C virus infection. Analysis of 68 Cases. Medicine 84:69\u201380, doi: 10.1097\/01.md.0000157577.69729.e6","journal-title":"Analysis of 68 Cases. Medicine"},{"key":"1002_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.83391-0","volume":"89","author":"RE Randall","year":"2008","unstructured":"Randall RE, Goodbourn S (2008) Interferons and viruses: an interplay between induction, signaling, antiviral responses and virus counter measures. J Gen Virol 89:1\u201347, doi: 10.1099\/vir.0.83391-0","journal-title":"J Gen Virol"},{"key":"1002_CR37","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.4049\/jimmunol.161.12.6567","volume":"161","author":"L Rogge","year":"1998","unstructured":"Rogge L, D\u2019Ambrosio D, Biffi M, Penna G, Minetti LJ, Presky DA, Adorini L, Sinigaglia F (1998) The role of Stat4 in species-specific regulation of Th cell development by type I IFNs. J Immunol 161:6567\u20136574","journal-title":"J Immunol"},{"key":"1002_CR38","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/1097-0142(19911001)68:7<1536::AID-CNCR2820680713>3.0.CO;2-B","volume":"68","author":"PJ Schilling","year":"1991","unstructured":"Schilling PJ, Kurzrock R, Kantarjian H, Gutterman JU, Talpaz M (1991) Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia. Cancer 68:1536\u20131537, doi: 10.1002\/1097-0142(19911001)68:7<1536::AID-CNCR2820680713>3.0.CO;2-B","journal-title":"Cancer"},{"key":"1002_CR39","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1055\/s-2001-19687","volume":"218","author":"N Stuebiger","year":"2001","unstructured":"Stuebiger N, Kotter I, Deuter C, Zierhut M (2001) Beh\u00e7et\u2019s disease: uveitis-therapy with interferon alpha2b \u2013 prospective clinical study in 33 patients. Klin Monatsbl Augenheilkd 218:768\u2013773, doi: 10.1055\/s-2001-19687","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"1002_CR40","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/clc.4960240406","volume":"24","author":"B Takase","year":"2001","unstructured":"Takase B, Uehata A, Fujioka T, Kondo T, Nishioka T, Isojima K, Satomura K, Ohsuzu F, Kurita A (2001) Endothelial dysfunction and decreased exercise tolerance in interferon-alpha therapy in chronic hepatitis C: relation between exercise hyperemia and endothelial function. Clin Cardiol 24:286\u2013290","journal-title":"Clin Cardiol"},{"key":"1002_CR41","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0168-8278(99)80093-2","volume":"30","author":"RC Tam","year":"1999","unstructured":"Tam RC, Pai B, Bard J, Lim C, Averett DR, Phan UT, Milovanovic T (1999) Ribavirin polarizes human T cell responses towards a type 1 cytokine profile. J Hepatol 30:376\u2013382, doi: 10.1016\/S0168-8278(99)80093-2","journal-title":"J Hepatol"},{"key":"1002_CR42","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/bjo.87.2.247","volume":"87","author":"KL Tu","year":"2003","unstructured":"Tu KL, Bowyer J, Schofield K, Harding S (2003) Severe interferon associated retinopathy. Br J Ophthalmol 87:247\u2013248, doi: 10.1136\/bjo.87.2.247","journal-title":"Br J Ophthalmol"},{"key":"1002_CR43","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1007\/s00417-006-0346-y","volume":"244","author":"I Tugal-Tutkun","year":"2006","unstructured":"Tugal-Tutkun I, G\u00fcney-Tafekli E, Urgancioglu M (2006) Results of interferon alpha-therapy in patients with Beh\u00e7et uveitis. Graefes Arch Clin Exp Ophthalmol 244:1692\u20131695, doi: 10.1007\/s00417-006-0346-y","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1002_CR44","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1445-5994.2007.01625.x","volume":"38","author":"KK Yan","year":"2008","unstructured":"Yan KK, Dininhan I, Freiman J, Zekry A (2008) Sarcoidosis presenting with granulomatous uveitis induced by pegilated interferon and ribavirin therapy for hepatitis C. Intern Med J 38:207\u2013210, doi: 10.1111\/j.1445-5994.2007.01625.x","journal-title":"Intern Med J"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-008-1002-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-008-1002-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-008-1002-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T21:56:03Z","timestamp":1684706163000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-008-1002-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,26]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["1002"],"URL":"https:\/\/doi.org\/10.1007\/s00417-008-1002-5","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,26]]}}}